🇺🇸 FDA
Patent

US 9120868

Recombinantly expressed Plasmodium CelTOS antigen and methods of use thereof

granted A61KA61K2039/55566A61K2039/57

Quick answer

US patent 9120868 (Recombinantly expressed Plasmodium CelTOS antigen and methods of use thereof) held by The United States of America as represented by the Secretary of the Army expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Sep 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2039/55566, A61K2039/57, A61K39/00, A61K39/015